FCA Venture Partners

The firm's public website does not name specific investment-committee members or a managing partner. The team's collective leadership is not broken out by name on the current site. In practice, an allocator would confirm the key decision-makers during due diligence, as names are not yet sourced here.

FCA draws its pipeline partly from its limited-partner base of healthcare organizations, provider groups, payers, and pharma executives. These strategic partners often surface companies addressing operational problems they experience firsthand. The firm also leans on its portfolio-CEO network and the concentration of healthcare operators in the Nashville market for referrals.

FCA Venture Partners operates as an asset manager raising capital from external strategic and institutional limited partners, not as a single-family office. The firm does not publicly disclose its ownership structure, but its fund-based deployment model and external LP base are consistent with a traditional private equity firm, not a family office.

FCA's strategy centers on direct investments into operating healthcare companies. The firm's website describes writing $2 million to $8 million checks into Seed and Series A/B rounds, with no mention of fund-of-fund commitments or investing as a limited partner in other venture funds.

FCA invests only in healthcare, organized across four internal themes: Providers, Payers, Pharma, and Innovative Care Delivery. It does not invest in other verticals such as enterprise software, fintech, or climate — making its negative screen anything outside healthcare technology and services.